首页 正文

Advances in immunotherapy of castration-resistant prostate cancer: bisphosphonates, phosphoantigens and more

{{output}}
Medical progress has prolonged life expectancy in patients with castration-resistant prostate cancer; however, the lack of effective therapies has fuelled an intensive search for novel modalities, including immunotherapy. Human gammadelta T-cells can be activa... ...